MYD88 and musculoskeletal system disorder: Thus, MyD88 may serve as a potential target for ES-62 in resetting baseline levels of HSCs, and OCPs, with this molecule providing the first example of a defined helminth ES product rewiring bone-remodeling progenitor populations in vivo to protect against the development of musculoskeletal disease.